Evidence map›Paper›PMID 33801221›Full record

ArticleInternational journal of molecular sciences2021

Analysis of

Alicja Słoczyńska, Matthew E Wand, Stefan Tyski, Agnieszka E Laudy

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Multicenter outbreak of plasmid-encodedAntimicrobial agents and chemotherapy · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Extensive Drug Resistance of Strong Biofilm-ProducingPathogens (Basel, Switzerland) · 2023
    Article
  10. Efflux-Related Carbapenem Resistance inInternational journal of molecular sciences · 2023
    Article
  11. Article
  12. Article
  13. Conventional and Real-Time PCR TargetingAntibiotics (Basel, Switzerland) · 2022
    Article
  14. Frontiers in microbiology · 2022
    Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Alicja SłoczyńskaDepartment of Pharmaceutical Microbiology, Medical University of Warsaw, PL 02-097 Warsaw, Poland.
Matthew E WandPublic Health England, National Infection Service, Porton Down, Salisbury SP4 0JG, UK.
Stefan TyskiDepartment of Pharmaceutical Microbiology, Medical University of Warsaw, PL 02-097 Warsaw, Poland.
Agnieszka E LaudyDepartment of Pharmaceutical Microbiology, Medical University of Warsaw, PL 02-097 Warsaw, Poland.
Medical University of Warsaw · PLPublic Health England · GB

Funding

Foundation for the Development of Diagnostics and Therapy, Warsaw, Poland REGON: 006220910, NIP: 5262173856, KRS: 0000195643Medical University of Warsaw FW15/PM2/16 and FW15/PM1/18
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DNA Transposable ElementsAcinetobacter baumanniiAcinetobacter InfectionsAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCarbapenemsDrug Resistance, BacterialHumansMultilocus Sequence TypingAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasescarbapenemaseCarbapenemsDNA Transposable ElementsCarbAcineto NP testcarbapenem resistanceCHDL enzymesinsertion sequencesMLSTmultidrug resistancePFGE

Identifiers

PMID33801221
PMCPMC7957893
OpenAlexW3135372586

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.